Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Current Leases: 2022-2024

Historic Current Leases for Day One Biopharmaceuticals (DAWN) over the last 3 years, with Dec 2024 value amounting to $10,000.

  • Day One Biopharmaceuticals' Current Leases rose 109.09% to $161,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $161,000, marking a year-over-year increase of 109.09%. This contributed to the annual value of $10,000 for FY2024, which is 97.55% down from last year.
  • Per Day One Biopharmaceuticals' latest filing, its Current Leases stood at $10,000 for FY2024, which was down 97.55% from $408,000 recorded in FY2023.
  • Day One Biopharmaceuticals' 5-year Current Leases high stood at $408,000 for FY2023, and its period low was $10,000 during FY2024.
  • Moreover, its 3-year median value for Current Leases was $405,000 (2022), whereas its average is $274,333.
  • Its Current Leases has fluctuated over the past 5 years, first grew by 0.74% in 2023, then tumbled by 97.55% in 2024.
  • Yearly analysis of 3 years shows Day One Biopharmaceuticals' Current Leases stood at $405,000 in 2022, then grew by 0.74% to $408,000 in 2023, then slumped by 97.55% to $10,000 in 2024.